PTO Gene Patenting Guidelines May Be Too Strict, Patent Official Suggests
Executive Summary
The Patent & Trademark Office's latest guidelines for demonstrating utility in patenting genomic material may be too strict to survive a court challenge, PTO Biotechnology Examining Group Director John Doll said during a public forum on gene patenting March 2 in Washington, D.C.